Evidence map›Paper›PMID 40550827›Full record

ArticleScientific reports2025

Morphological, vascular, and functional changes in macular telangiectasia type 2 in Egyptian patients.

Shaimaa Ibrahim Gafar, Hany Hamza, Ihab Abdelaziz, Rania G Estawro, Shaymaa Hassan Salah

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shaimaa Ibrahim GafarMemorial lnstitute of Ophthalmology, Cairo, Egypt.
Hany HamzaOphthalmology department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Ihab AbdelazizMemorial lnstitute of Ophthalmology, Cairo, Egypt.
Rania G EstawroWatany Eye Hospital, Cairo, Egypt.
Shaymaa Hassan SalahOphthalmology department, Faculty of Medicine, Cairo University, Cairo, Egypt. shaimaa.sayed@kasralainy.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little documented studies regarding analysis of macular telangiectasia type 2 in Egyptian patients. This prospective study included 24 eyes with MacTel-2, and 24 control eyes. Spectral-domain optical coherence tomography Angiography (OCT-A) was performed. Staging of eyes with MacTel-2, quantification of Foveal and parafoveal vascular density and full retinal thickness were performed. In MacTel-2 eyes, the superficial capillary vessel density was significantly decreased in the temporal, superior and inferior para-foveal area (p-value = 0.004, < 0.001 and 0.002 respectively). Only temporal parafoveal deep vessel density showed significant decrease in the MacTel-2 group as compared with the normal control group (49.6% versus 54.01%, p value = 0.010). There was a statistically significant decrease in the foveal and all the para-foveal thickness as compared with normal control group (P < 0.001). One-fourth of cases were classified as stage 4 MacTel-2. The patterns of neovessels were sea-fan, tangled or dead tree network, equally distributed among the six affected eyes. A significant reduction in both foveal density and visual acuity was documented with disease progression. This study emphasizes the role of OCT-A in diagnosis, staging and identification of neovascular pattern of MacTel-2. Furethermore, this study is considered one of the few Egyptian studies in staging the disease providing correlation to visual acuity, macular thickness and vessel density affection.

Indexed as

Macula LuteaRetinal TelangiectasisRetinal VesselsAdultEgyptFemaleFluorescein AngiographyFovea CentralisHumansMaleMiddle AgedProspective StudiesTomography, Optical CoherenceVisual AcuityMacTel-2Neovessels in MacTel-2OCT-A in Mac Tel-2Retino-retinal anastomoses

Identifiers

PMID40550827
PMCPMC12185728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.